151 related articles for article (PubMed ID: 36482163)
1. Development and evaluation of transdermal delivery system of tranylcypromine for the treatment of depression.
Shrestha N; Banga AK
Drug Deliv Transl Res; 2023 Apr; 13(4):1048-1058. PubMed ID: 36482163
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch.
Ganti SS; Bhattaccharjee SA; Murnane KS; Blough BE; Banga AK
Int J Pharm; 2018 Oct; 550(1-2):71-78. PubMed ID: 30125654
[TBL] [Abstract][Full Text] [Related]
3. Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.
Ameen D; Michniak-Kohn B
Eur J Pharm Biopharm; 2019 Jun; 139():262-271. PubMed ID: 30981946
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine.
Vora D; Banga AK
Expert Opin Drug Deliv; 2022 Nov; 19(11):1539-1548. PubMed ID: 36242524
[TBL] [Abstract][Full Text] [Related]
5. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of α-asarone transdermal patches based on hot-melt pressure-sensitive adhesives.
Yu Z; Liang Y; Liang W
AAPS PharmSciTech; 2013 Mar; 14(1):294-300. PubMed ID: 23307595
[TBL] [Abstract][Full Text] [Related]
7. Impact of Different Mixing Methods on the Performance of Suspension-Based Transdermal Delivery Systems.
Bhattaccharjee SA; Kale M; Le N; Banga AK
AAPS PharmSciTech; 2021 May; 22(4):150. PubMed ID: 33973096
[TBL] [Abstract][Full Text] [Related]
8. Investigating transdermal delivery of vitamin D3.
Alsaqr A; Rasoully M; Musteata FM
AAPS PharmSciTech; 2015 Aug; 16(4):963-72. PubMed ID: 25609377
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of alprazolam from a monolithic patch: formulation based on in vitro characterization.
Soler LI; Boix A; Lauroba J; Colom H; Domenech J
Drug Dev Ind Pharm; 2012 Oct; 38(10):1171-8. PubMed ID: 22204649
[TBL] [Abstract][Full Text] [Related]
10. A strong, silk protein-inspired tissue adhesive with an enhanced drug release mechanism for transdermal drug delivery.
Song H; Wang L; Wu J; Liu J; Liu C; Guo J; Fang L
Acta Biomater; 2024 Jun; 181():133-145. PubMed ID: 38641185
[TBL] [Abstract][Full Text] [Related]
11. Formulation optimization of a drug in adhesive transdermal analgesic patch.
Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
Drug Dev Ind Pharm; 2016 Jun; 42(6):862-870. PubMed ID: 26227813
[TBL] [Abstract][Full Text] [Related]
12. Effect of Different Pressure-Sensitive Adhesives on Performance Parameters of Matrix-Type Transdermal Delivery Systems.
Bozorg BD; Banga AK
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32121515
[TBL] [Abstract][Full Text] [Related]
13. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
14. Design of a tulobuterol patch with improved mechanical properties: effect of transdermal permeation enhancers on the release process of metal ligand-based acrylic pressure-sensitive adhesives.
Nan L; Song H; Wang H; Mi R; Wang X; Fang L
Drug Deliv Transl Res; 2024 Mar; 14(3):802-811. PubMed ID: 38082031
[TBL] [Abstract][Full Text] [Related]
15. Enhancing Transdermal Delivery: Investigating the Impact of Permeation Promoters on Ibuprofen Release and Penetration from Medical Patches-In Vitro Research.
Bednarczyk P; Nowak A; Duchnik W; Kucharski Ł; Ossowicz-Rupniewska P
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958615
[TBL] [Abstract][Full Text] [Related]
16. Development of matrix-type transdermal delivery of lornoxicam: in vitro evaluation and pharmacodynamic and pharmacokinetic studies in albino rats.
Baviskar DT; Parik VB; Jain DJ
PDA J Pharm Sci Technol; 2013; 67(1):9-22. PubMed ID: 23385560
[TBL] [Abstract][Full Text] [Related]
17. Development of a drug-in-adhesive patch combining ion pair and chemical enhancer strategy for transdermal delivery of zaltoprofen: pharmacokinetic, pharmacodynamic and in vitro/in vivo correlation evaluation.
Cui H; Quan P; Zhou Z; Fang L
Drug Deliv; 2016 Nov; 23(9):3461-3470. PubMed ID: 27257038
[TBL] [Abstract][Full Text] [Related]
18. Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV.
Puri A; Bhattaccharjee SA; Zhang W; Clark M; Singh O; Doncel GF; Banga AK
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30970630
[TBL] [Abstract][Full Text] [Related]
19. Skin Delivery and Irritation Potential of Phenmetrazine as a Candidate Transdermal Formulation for Repurposed Indications.
Jiang Y; Murnane KS; Bhattaccharjee SA; Blough BE; Banga AK
AAPS J; 2019 May; 21(4):70. PubMed ID: 31152318
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of physical and chemical enhancement techniques for transdermal delivery of linagliptin.
Karve T; Banga AK
Int J Pharm; 2024 Apr; 654():123992. PubMed ID: 38479485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
